These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29970707)

  • 1. Association of
    Liang Y; Han W; Yan H; Mao Q
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S463-S467. PubMed ID: 29970707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CYP3A5 polymorphisms and the risk of adverse events in patients undergoing clopidogrel therapy: Meta-analysis.
    Wang YQ; Wang CH; Zhang JH
    Thromb Res; 2016 Nov; 147():1-6. PubMed ID: 27649539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.
    Vaarala MH; Mattila H; Ohtonen P; Tammela TL; Paavonen TK; Schleutker J
    Int J Cancer; 2008 Jun; 122(11):2511-6. PubMed ID: 18306354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.
    He XF; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Wei W
    Tumour Biol; 2014 Oct; 35(10):9859-77. PubMed ID: 24989928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.
    Wang BS; Liu Z; Xu WX; Sun SL
    Tumour Biol; 2013 Aug; 34(4):2357-66. PubMed ID: 23584898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between three polymorphisms (rs1800629, rs361525 and rs1799724) in the tumor necrosis factor-α gene and susceptibility to prostate cancer: a comprehensive meta-analysis.
    Yin L; Yue C; Jing H; Yu H; Zuo L; Liu T
    Hereditas; 2020 Apr; 157(1):11. PubMed ID: 32264962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
    Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
    Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of CYP2C19 and CYP3A5 gene polymorphisms with myocardial infarction].
    Qi L; Liang W; Qiao H; Wang R; Han J; Xing X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):87-91. PubMed ID: 33423267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
    Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
    Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
    Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
    Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
    Chang K; Deng S; Lu W; Wang F; Jia S; Li F; Yu L; Chen M
    PLoS One; 2012; 7(7):e41519. PubMed ID: 22911807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association in
    Bellah SF; Salam MA; Billah SMS; Karim MR
    Ann Hum Biol; 2023 Feb; 50(1):63-74. PubMed ID: 36688864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
    Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
    Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
    Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
    Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL; Tian Z; Zhao L; Zhang CL
    Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients.
    Yi X; Zhang B; Wang C; Liao D; Lin J; Chi L
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):521-9. PubMed ID: 25534367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.
    Su XJ; Zeng XT; Fang C; Liu TZ; Wang XH
    Oncotarget; 2017 May; 8(20):33953-33960. PubMed ID: 28430620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
    Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
    Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.